Influence of Dose and Antiepileptic Comedication on Lacosamide Serum Concentrations in Patients With Epilepsy of Different Ages

被引:19
|
作者
May, Theodor W. [1 ]
Helmer, Renate [1 ]
Bien, Christian G. [2 ]
Brandt, Christian [2 ]
机构
[1] Mara Hosp, Soc Epilepsy Res, Bielefeld, Germany
[2] Mara Hosp, Bethel Epilepsy Ctr, Bielefeld, Germany
关键词
lacosamide; antiepileptic drugs; drug interactions; age; therapeutic drug monitoring; NO PHARMACOKINETIC INTERACTION; TOTAL-BODY WATER; VALPROIC ACID; ADULTS; METHSUXIMIDE; CHILDREN;
D O I
10.1097/FTD.0000000000000538
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background: Lacosamide (LCM) is a new antiepileptic drug (AED). The purpose of the study was to investigate the effects of LCM dose, body weight, height, sex, age, and concomitant AEDs on LCM trough serum concentrations (at a steady state) in patients with epilepsy. Methods: A total number of 3154 blood samples of 973 consecutive patients of the Mara Hospital (Bethel Epilepsy Centre) were evaluated. Generalized estimating equation (GEE) models were used for statistical analyses. Results: GEE analyses showed that LCM trough serum concentrations were significantly correlated with the body weight-normalized LCM dose (range: 0.44-25.7 mg/kg; 45-1050 mg) and significantly dependent on comedication and age. Compared with adults (18-60 years), the LCM trough serum concentrations of children aged 6-12 years and children younger than 6 years were significantly lower (-21% to -38%, respectively) and those of elderly patients (. 60 years) were significantly higher (+20%). Sex had no significant influence. Carbamazepine, phenytoin, primidone, phenobarbital, and methsuximide decreased LCM trough serum concentrations significantly by 30%, 32%, 34%, 39%, and 41%, respectively, whereas other AEDs (eg, oxcarbazepine, eslicarbazepine acetate, valproate) had no significant or only a minor impact (zonisamide) on LCM trough concentrations. In children, the effect of enzyme-inducing AEDs was more marked. Of note, the number of blood samples (n = 151) of patients younger than 12 (n = 78) was comparatively low. Alternative GEE models confirmed the effect of comedication, whereas the effect of age, especially in children, depended on adjustment of LCM dosage to body weight, body surface area, or approximated volume of distribution. Conclusions: In accordance with previous therapeutic drug monitoring studies, our results confirmed that enzyme inducers reduce the LCM trough serum concentrations by 30%-40%. In children, the effects of comedication are more pronounced but should be confirmed by further studies.
引用
收藏
页码:620 / 627
页数:8
相关论文
共 50 条
  • [31] Lamotrigine serum concentration-to-dose ratio: Influence of age and concomitant antiepileptic drugs and dosage implications
    Armijo, JA
    Bravo, J
    Cuadrado, A
    Herranz, JL
    THERAPEUTIC DRUG MONITORING, 1999, 21 (02) : 182 - 190
  • [32] Topiramate serum concentration-to-dose ratio -: Influence of age and concomitant antiepileptic drugs and monitoring implications
    Adin, J
    Gómez, MC
    Blanco, Y
    Herranz, JL
    Armijo, JA
    THERAPEUTIC DRUG MONITORING, 2004, 26 (03) : 251 - 257
  • [33] Comparison of brain extracellular fluid, brain tissue, cerebrospinal fluid, and serum concentrations of antiepileptic drugs measured intraoperatively in patients with intractable epilepsy
    Rambeck, B
    Jürgens, UH
    May, TW
    Pannek, HW
    Behne, F
    Ebner, A
    Gorji, A
    Straub, H
    Speckmann, EJ
    Pohlmann-Eden, B
    Löscher, W
    EPILEPSIA, 2006, 47 (04) : 681 - 694
  • [34] Long-term outcome of hemispheric surgery at different ages in 61 epilepsy patients
    Althausen, Anita
    Gleissner, Ulrike
    Hoppe, Christian
    Sassen, Robert
    Buddewig, Svenja
    von Lehe, Marec
    Schramm, Johannes
    Elger, Christian Erich
    Helmstaedter, Christoph
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2013, 84 (05) : 529 - 536
  • [35] Efficacy and safety of a new antiepileptic drug lacosamide in patients with focal epilepsy: data of double-blind placebo controlled trials
    Milchakova, L. E.
    Guekht, A. B.
    ZHURNAL NEVROLOGII I PSIKHIATRII IMENI S S KORSAKOVA, 2010, 110 (03) : 39 - 43
  • [36] 10-hydroxycarbazepine serum concentration-to-oxcarbazepine dose ratio - Influence of age and concomitant antiepileptic drugs
    Armijo, JA
    Vega-Gil, N
    Shushtarian, M
    Adin, J
    Herranz, JL
    THERAPEUTIC DRUG MONITORING, 2005, 27 (02) : 199 - 204
  • [37] Therapeutic Drug Monitoring for Perampanel in Japanese Epilepsy Patients: Influence of Concomitant Antiepileptic Drugs
    Yamamoto, Yoshiaki
    Usui, Naotaka
    Nishida, Takuji
    Takahashi, Yukitoshi
    Imai, Katsumi
    Kagawa, Yoshiyuki
    Inoue, Yushi
    THERAPEUTIC DRUG MONITORING, 2017, 39 (04) : 446 - 449
  • [38] The Assessment of Serum Concentrations of AGEs and Their Soluble Receptor (sRAGE) in Multiple Sclerosis Patients
    Damasiewicz-Bodzek, Aleksandra
    Labuz-Roszak, Beata
    Kumaszka, Bartlomiej
    Tadeusiak, Bartosz
    Tyrpien-Golder, Krystyna
    BRAIN SCIENCES, 2021, 11 (08)
  • [39] The effect of serum levetiracetam concentrations on therapeutic response and IL1-beta concentration in patients with epilepsy
    Gulcebi, Medine I.
    Kendirli, Tansel
    Turgan, Zehra Asik
    Patsalos, Philip N.
    Onat, Filiz Yilmaz
    EPILEPSY RESEARCH, 2018, 148 : 17 - 22
  • [40] Relationship between serum mono-hydroxy-carbazepine concentrations and adverse effects in patients with epilepsy on high-dose oxcarbazepine therapy
    Striano, Salvatore
    Striano, Pasquale
    Di Nocera, Pierpaolo
    Italiano, Domenico
    Fasiello, Cecilia
    Ruosi, Patrizia
    Bilo, Leonilda
    Pisani, Francesco
    EPILEPSY RESEARCH, 2006, 69 (02) : 170 - 176